
GC38841
RIPK1-IN-4
Also known as 1-[4-(1-aminoisoquinolin-5-yl)phenyl]-3-(5-tert-butyl-1,2-oxazol-3-yl)urea
RIPK1-IN-4 (compound 8) is a potent and selective type II kinase inhibitor of receptor interacting protein 1 (RIP1) kinase and binds to a DLG-out inactive form of RIP1 with an IC50s of 16 nM and 10 nM for RIP1 and ADP-Glo kinase
ChemicalCAS1481641-08-0MW401.46FormulaC23H23N5O2
- CAS number
- 1481641-08-0
- Molecular weight
- 401.46
- Formula
- C23H23N5O2
- Solubility
- DMSO: 250 mg/mL (622·73 mM)
- InChIKey
- SLRYMOUSQMDJPH-UHFFFAOYSA-N
- Catalogue number
- GC38841
- Brand
- GLPBIO
Computed properties PubChem CID 71816195 · XLogP 4.4 · TPSA 106 Ų · H-bond donors 3
- XLogP
- 4.4
- TPSA
- 106 Ų
- H-bond donors
- 3
- H-bond acceptors
- 5
- Rotatable bonds
- 4
- Heavy atoms
- 30
SMILES CC(C)(C)C1=CC(=NO1)NC(=O)NC2=CC=C(C=C2)C3=CC=CC4=C3C=CN=C4N
Computed descriptors from PubChem (CID 71816195), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il